← Back to Search

CEDM + CEDBT for Breast Cancer

Q: What is the upper limit for the number of participants that can be enrolled in this medical study?

<p>Confirmed by information available on clinicaltrials.gov, this study is actively seeking participants. Initially shared on March 23rd, 2024 and most recently revised on March 5th, 2024, the trial aims to enroll a total of 30 individuals at one designated site.</p>

Q: Are eligible patients able to enroll in this ongoing trial at the present time?

<p>Indeed, details on clinicaltrials.gov specify that this medical investigation is actively pursuing candidates. The trial was initially listed on March 23rd, 2024 and last revised on March 5th, 2024. Enrollment targets include recruiting 30 participants from a single site.</p>

Phase < 1

Recruiting

Led By Alison Stopeck, MD

Research Sponsored by Alison Stopeck

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately before definitive breast surgery

Awards & highlights

Study Summary

This trial is comparing a special type of mammogram using contrast with breast MRI to see how well they predict the effect of chemotherapy on breast cancer. Participants will have mammograms and contrast agents injected before surgery

Who is the study for?

This trial is for individuals with early-stage, invasive breast cancer who are planning to undergo at least four cycles of neoadjuvant chemotherapy before surgery. Participants will have mammograms using a contrast agent during/after chemo but before surgery.Check my eligibility

What is being tested?

The study compares contrast-enhanced digital mammography (CEDM) and digital breast tomosynthesis (CEDBT) against MRI in predicting the effectiveness of pre-surgery chemotherapy on eliminating cancer cells.See study design

What are the potential side effects?

Potential side effects may include discomfort from needle insertion for the contrast agent, allergic reactions to the contrast medium, and exposure to low levels of radiation during mammography.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately after definitive breast surgery, up to 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately after definitive breast surgery, up to 24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after definitive breast surgery, up to 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Accuracy of (CEDM+CEDBT) to predict NAC treatment effects

Secondary outcome measures

Accuracy of (CEDM+CEDBT) to detect residual tumor compared with standard of care MRI

Trial Design

1Treatment groups

Experimental Treatment

Group I: CEDM + CEDBTExperimental Treatment3 Interventions

Participants undergo CEDM + CEDBT imaging after every 4-6 cycles of neoadjuvant chemotherapy prior to surgery (imaging may occur up to 2 times)

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Alison StopeckLead Sponsor

3 Previous Clinical Trials

180 Total Patients Enrolled

2 Trials studying Breast Cancer

180 Patients Enrolled for Breast Cancer

Alison Stopeck, MDPrincipal InvestigatorStony Brook Cancer Center

4 Previous Clinical Trials

170 Total Patients Enrolled

1 Trials studying Breast Cancer

30 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit for the number of participants that can be enrolled in this medical study?

"Confirmed by information available on clinicaltrials.gov, this study is actively seeking participants. Initially shared on March 23rd, 2024 and most recently revised on March 5th, 2024, the trial aims to enroll a total of 30 individuals at one designated site."

Answered by AI

Are eligible patients able to enroll in this ongoing trial at the present time?

"Indeed, details on clinicaltrials.gov specify that this medical investigation is actively pursuing candidates. The trial was initially listed on March 23rd, 2024 and last revised on March 5th, 2024. Enrollment targets include recruiting 30 participants from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

Alison Stopeck 2024. "Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06220214.

All > Womens Health